Home › Data From Phase 3 Pivotal Studies Show Amgen's Novel...
 

Keywords :   


Data From Phase 3 Pivotal Studies Show Amgen's Novel...

2014-03-30 17:13:28| Biotech - Topix.net

Data From Two Separate Phase 3 Studies of Evolocumab , a PCSK9 Inhibitor, Presented in Late-Breaking Clinical Trials Session at ACC.14 - Data Add to the Three Pivotal Studies Presented Yesterday /PRNewswire/ -- Amgen today announced new detailed data from two Phase 3 pivotal studies that showed treatment with its novel investigational ... (more)

Tags: show data studies phase

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
06.10Glatfelter Develops Biobased Espresso Lid Material
06.10Tropical Storm Milton Potential Storm Surge Flooding Map
06.10Tropical Storm Milton Probabilistic Storm Surge Graphics
06.10Firms urge mayor to rethink congestion charge plan
06.10Tropical Storm Milton Public Advisory Number 5
06.10Summary for Tropical Storm Milton (AT4/AL142024)
06.10Tropical Storm Milton Graphics
06.10Tropical Storm Milton Graphics
More »